Clinical Trial

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated March 26, 2024 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aimed to investigate the value of a novel strategy of intermittent systematic chemotherapy (ISC) in widely metastatic nasopharyngeal carcinoma (wmNPC) patients who achieve objective response after systematic chemotherapy (SC).
Trial Details
NCT Number NCT06331845
Lead Sponsor Fujian Cancer Hospital
Conditions Metastatic Nasopharyngeal Carcinoma, Intermittent Systematic Chemotherapy
Enrollment 39 participants
Start Date 2024-05-01
Primary Completion 2026-05-01 (estimated)
Study Completion 2028-05-01 (estimated)
Updated on ClinicalTrials.gov 2024-03-26